Call for proposals to develop early warning features and guidance in the area of pricing through the EURIPID database, based on competition cases
Programme Category
Programme Name
Programme Description
The Programme aims to improve and promote health in the Union to reduce the burden of communicable and non-communicable diseases by:
- protecting people from serious cross-border health threats
- improving the availability, accessibility and affordability of medicines, medical devices and other crisis-related products in the EU
- strengthening national health systems
Identifier Code
Call
Summary
The scope of this action is to develop early warning mechanisms and guidance in the area of pricing through the EURIPID database, based on lessons from competition cases, in particular on excessive pricing.
Detailed Call Description
This action will create common approaches to verify claims on price information and to provide appropriate guidance to adjust pricing methodologies.
The activities will include the monitoring of strategic sequencing of price increases of threats to de-list reimbursable medicines or withdraw of medicines. These activities may prevent price increases based on unfounded claims to recover investments and increased costs.
The activities will include the monitoring of strategic sequencing of price increases meant to game the External Reference Pricing system and monitoring.
The extension of the EURIPID database to develop warning features is meant to identify strategic price increases and threats to de-list or withdraw medicines. As part of the activities, it would be necessary to explore synergies with other databases to complement early warning information (like verification of shortages and/or market withdrawals). (Further details in the call document p. 30)
Call Total Budget
Financing percentage by EU or other bodies / Level of Subsidy or Loan
80%
Thematic Categories
- Health
- Justice - Security
Eligibility for Participation
- Central Government
- Private Bodies
- State-owned Enterprises
Eligibility For Participation Notes
In order to be eligible for funding, the applicants (beneficiaries and affiliated entities) must be legal entities (public or private bodies) established in EU Member States or EEA countries and countries associated to the EU4Health Programme (third countries, candidate countries and potential candidate countries, neighbourhood countries) or countries which are in ongoing negotiations for an association agreement.
For the specific eligibility criteria (including consortium composition and eligible applications) of each topic, please visit the detailed description of the topic of your interest in the call document.
Call Opening Date
Call Closing Date
National Contact Point(s)
Ministry of Health, Department of European Affairs
Ms MAKRIGIORGI Elena
emakrigiorgi@moh.gov.cy
(Publish Date: 25/02/2022-for internal use only)
EU Contact Point
Stefan DE KEERSMAECKER
Telephone: +32 2 298 46 80
Email: stefan.de-keersmaecker@ec.europa.eu
Darragh CASSIDY
Telephone: +32 2 298 39 78
Email: darragh.cassidy@ec.europa.eu